Impact of Shenfu Injection on 28-Day Mortality Rates in Critically Ill Sepsis Patients: A Retrospective Cohort Analysis with Propensity Score Matching - Takeaways - MDSpire

Impact of Shenfu Injection on 28-Day Mortality Rates in Critically Ill Sepsis Patients: A Retrospective Cohort Analysis with Propensity Score Matching

  • By

  • Jinrong Li

  • Yunxin Deng

  • Yanxia Huang

  • Liya Gao

  • Congjie Zhu

  • Haiming Jiang

  • Fengyong Yang

  • Yufeng Chu

  • Ranran Li

  • Mei Meng

  • February 11, 2026

  • 0 min

Share

  • 1

    Sepsis is a critical condition with high mortality, necessitating effective management strategies beyond standard Western medicine.

  • 2

    Shenfu Injection (SFI), derived from traditional Chinese medicine, shows potential in improving organ function and reducing mortality in sepsis patients.

  • 3

    This study utilized a large-scale retrospective cohort design to analyze the impact of SFI on 28-day mortality rates in critically ill sepsis patients.

  • 4

    Propensity score matching was employed to address imbalances between patients receiving SFI and those receiving standard care.

  • 5

    The study aims to provide high-quality clinical evidence regarding the efficacy and safety of SFI in conjunction with standard sepsis treatment.

Original Source(s)

Impact of Shenfu Injection on 28-Day Mortality Rates in Critically Ill Sepsis Patients: A Retrospective Cohort Analysis with Propensity Score Matching

  • by Jinrong Li, Yunxin Deng, Yanxia Huang, Liya Gao, Congjie Zhu, Haiming Jiang, Fengyong Yang, Yufeng Chu, Ranran Li, Mei Meng

  • February 11, 2026

Related Content

Compliance of procalcitonin-guided antibiotic therapy in adult infectious patients in China: a multicenter real-world retrospective study

Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing

7 Days Noninferior in Bacteremia

BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.